Product Description: SuO-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the peptide SuO-Val-Cit-PAB[1].
Applications: Cancer-programmed cell death
Formula: C63H97N11O16
References: [1]Kamath AV, et al. Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates. Pharm Res. 2015 Nov;32(11):3470-9.
Molecular Weight: 1264.51
Compound Purity: 99.24
Research Area: Cancer
Solubility: DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)
Target: Drug-Linker Conjugates for ADC